ROSA MARÍA
AYALA DÍAZ
Profesora titular de universidad
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (14)
2023
-
CNL and aCML should be considered as a single entity based on molecular profiles and outcomes
Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681
-
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
Frontiers in immunology
-
Corrigendum: Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients (Frontiers in Immunology, (2023), 14, (1188818), 10.3389/fimmu.2023.1188818)
Frontiers in Immunology
2019
-
Minimal residual disease monitoring with next- generation sequencing methodologies in hematological malignancies
International Journal of Molecular Sciences, Vol. 20, Núm. 11
2018
-
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
Annals of Hematology, Vol. 97, Núm. 11, pp. 2089-2098
-
Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology
British Journal of Haematology
2016
-
Leucemia mieloide crónica en España: sus características de presentación han cambiado. Sección española del registro poblacional EUTOS
Revista Clinica Espanola, Vol. 216, Núm. 6, pp. 293-300
2014
-
Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm
Leukemia, Vol. 28, Núm. 4, pp. 823-829
2012
2011
-
Asociación entre hiperhomocisteinemia y esteatosis hepática en pacientes con hepatitis crónica C
Medicina Clinica, Vol. 136, Núm. 2, pp. 45-49
2009
-
Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL expression in acute myeloid leukemia
American Journal of Hematology, Vol. 84, Núm. 2, pp. 79-86
2006
-
Application of self-quenched JH consensus primers for real-time quantitative of PCR of IGH gene to minimal residual disease evaluation in multiple myeloma
Journal of Molecular Diagnostics, Vol. 8, Núm. 3, pp. 364-370
2004
-
The use of fluorescent molecular beacons in real time PCR of IgH gene rearrangements for quantitative evaluation of multiple myeloma
Clinical and Laboratory Haematology, Vol. 26, Núm. 1, pp. 31-35